E2F1 and prostate cancer: Increased expression of E2F1 commonly observed in EMT-like cell lines is also evident from several other aggressive tumor entities such as pancreatic, lung, and prostate cancer (Supplementary Fig. 6) as well as cutaneous melanoma9.